PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
- PMID: 19276888
- PMCID: PMC3627054
- DOI: 10.1097/MOL.0b013e328328d0a4
PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Abstract
Purpose of review: Peroxisome proliferator-activated receptor gamma coactivator-1-alpha (PGC-1alpha) has been extensively described as a master regulator of mitochondrial biogenesis. However, PGC-1alpha activity is not constant and can be finely tuned in response to different metabolic situations. From this point of view, PGC-1alpha could be described as a mediator of the transcriptional outputs triggered by metabolic sensors, providing the idea that these sensors, together with PGC-1alpha, might be weaving a network controlling cellular energy expenditure. In this review, we will focus on how disorders such as type 2 diabetes and the metabolic syndrome might be related to an abnormal and improper function of this network.
Recent findings: Two metabolic sensors, AMP-activated protein kinase (AMPK) and SIRT1 have been described to directly affect PGC-1alpha activity through phosphorylation and deacetylation, respectively. Although the physiological relevance of these modifications and their molecular consequences are still largely unknown, recent insight from different in-vivo transgenic models clearly suggests that AMPK, SIRT1 and PGC-1alpha might act as an orchestrated network to improve metabolic fitness.
Summary: Metabolic sensors such as AMPK and SIRT1, gatekeepers of the activity of the master regulator of mitochondria, PGC-1alpha, are vital links in a regulatory network for metabolic homeostasis. Together, these players explain many of the beneficial effects of physical activity and dietary interventions in our battle against type 2 diabetes and related metabolic disorders. Hence, understanding the mechanisms by which they act could guide us to identify and improve preventive and therapeutic strategies for metabolic diseases.
Figures
Similar articles
-
The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.Adipocyte. 2020 Dec;9(1):484-494. doi: 10.1080/21623945.2020.1807850. Adipocyte. 2020. PMID: 32835596 Free PMC article.
-
SIRT5 is under the control of PGC-1α and AMPK and is involved in regulation of mitochondrial energy metabolism.FASEB J. 2014 Jul;28(7):3225-37. doi: 10.1096/fj.13-245241. Epub 2014 Mar 31. FASEB J. 2014. PMID: 24687991
-
Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α.Arthritis Rheumatol. 2015 May;67(8):2141-53. doi: 10.1002/art.39182. Arthritis Rheumatol. 2015. PMID: 25940958 Free PMC article.
-
Sirt1 and the Mitochondria.Mol Cells. 2016 Feb;39(2):87-95. doi: 10.14348/molcells.2016.2318. Epub 2016 Feb 2. Mol Cells. 2016. PMID: 26831453 Free PMC article. Review.
-
Deacetylation of PGC-1α by SIRT1: importance for skeletal muscle function and exercise-induced mitochondrial biogenesis.Appl Physiol Nutr Metab. 2011 Oct;36(5):589-97. doi: 10.1139/h11-070. Epub 2011 Sep 2. Appl Physiol Nutr Metab. 2011. PMID: 21888529 Review.
Cited by
-
The Role of Mitochondrial Dysfunction in CKD-Related Vascular Calcification: From Mechanisms to Therapeutics.Kidney Int Rep. 2024 May 14;9(9):2596-2607. doi: 10.1016/j.ekir.2024.05.005. eCollection 2024 Sep. Kidney Int Rep. 2024. PMID: 39291213 Free PMC article. Review.
-
Is SIRT3 and Mitochondria a Reliable Target for Parkinson's Disease and Aging? A Narrative Review.Mol Neurobiol. 2024 Sep 17. doi: 10.1007/s12035-024-04486-w. Online ahead of print. Mol Neurobiol. 2024. PMID: 39287746 Review.
-
Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer's disease.Heliyon. 2024 Aug 17;10(17):e36470. doi: 10.1016/j.heliyon.2024.e36470. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281517 Free PMC article. Review.
-
Resveratrol: A Multifaceted Guardian against Anxiety and Stress Disorders-An Overview of Experimental Evidence.Nutrients. 2024 Aug 26;16(17):2856. doi: 10.3390/nu16172856. Nutrients. 2024. PMID: 39275174 Free PMC article. Review.
-
8-Prenylgenistein Isoflavone in Cheonggukjang Acts as a Novel AMPK Activator Attenuating Hepatic Steatosis by Enhancing the SIRT1-Mediated Pathway.Int J Mol Sci. 2024 Sep 8;25(17):9730. doi: 10.3390/ijms25179730. Int J Mol Sci. 2024. PMID: 39273677 Free PMC article.
References
-
- DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982;23:313–9. - PubMed
-
- Lillioja S, Mott DM, Howard BV, et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med. 1988;318:1217–25. - PubMed
-
- He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes. 2001;50:817–23. - PubMed
-
- Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol. 1997;83:166–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials